Skip to main content
Clinical Trials/IRCT2014100419396N1
IRCT2014100419396N1
Completed
未知

Investigating the effectiveness of Tranexamic acid in blood loss during and after cesarean section

Hormozgan University of Medical Sciences0 sites200 target enrollmentStarted: TBDLast updated:

Overview

Phase
未知
Status
Completed
Enrollment
200

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 40 years (—)
Sex
Female

Inclusion Criteria

  • All women between 20 to 40 years of age who were in their 37th to 40th week of pregnancy and had opted for a cesarean surgery entered the study.
  • The following were excluded: those with an experience of twinning; placenta abnormalities; severe pre\-eclampsia; macrosomy; polyhydramnios; previous cesarean or abdominal surgeries; kidney, brain, blood or liver disorders, coagulopathy; anemia; thrombophilia; thromboembolic disorders; allergy to Tranexamic acid. In addition, patients whose BMI was higher than 30 were excluded from the study.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials